Stock ANG6 ANG LIFESCIENCES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials ANG Lifesciences India Limited

Equities

ANG6

INE236W01016

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 10:27:15 26/06/2024 BST 		5-day change 1st Jan Change
51.29 INR -0.60% Intraday chart for ANG Lifesciences India Limited -2.34% -26.11%
06-13 ANG Lifesciences India Limited Announces Cessation of Pawanjit Singh as Independent Director CI
05-30 ANG Lifesciences India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 287.2 248.8 156.5 444.7 2,432 993.1
Enterprise Value (EV) 1 446.6 424.1 328.9 837.7 3,135 1,659
P/E ratio 7.72 x 4.41 x 2.57 x 6.33 x 6.03 x -377 x
Yield - - - - 0.43% -
Capitalization / Revenue 0.38 x 0.2 x 0.12 x 0.29 x 0.69 x 0.45 x
EV / Revenue 0.59 x 0.35 x 0.26 x 0.54 x 0.88 x 0.75 x
EV / EBITDA 6.31 x 3.62 x 2.62 x 6 x 4.63 x 7.36 x
EV / FCF -2.57 x -11.5 x -243 x -4.24 x -15.2 x 23.1 x
FCF Yield -39% -8.72% -0.41% -23.6% -6.58% 4.33%
Price to Book 1.24 x 0.86 x 0.45 x 1.07 x 2.9 x 1.15 x
Nbr of stocks (in thousands) 12,958 12,958 12,958 12,958 12,958 13,058
Reference price 2 22.16 19.20 12.08 34.32 187.7 76.05
Announcement Date 03/09/18 10/09/19 10/12/20 28/10/21 07/09/22 08/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 760.4 1,217 1,268 1,544 3,543 2,199
EBITDA 1 70.8 117.2 125.6 139.7 677.2 225.3
EBIT 1 58.88 106 113.3 126.6 618.6 134.6
Operating Margin 7.74% 8.71% 8.93% 8.2% 17.46% 6.12%
Earnings before Tax (EBT) 1 49.53 81.09 84.06 101.4 535 26.25
Net income 1 37.24 56.49 60.96 70.28 403.2 -2.621
Net margin 4.9% 4.64% 4.81% 4.55% 11.38% -0.12%
EPS 2 2.872 4.356 4.704 5.423 31.11 -0.2017
Free Cash Flow 1 -174 -36.98 -1.353 -197.6 -206.3 71.77
FCF margin -22.89% -3.04% -0.11% -12.8% -5.82% 3.26%
FCF Conversion (EBITDA) - - - - - 31.85%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - 0.8000 -
Announcement Date 03/09/18 10/09/19 10/12/20 28/10/21 07/09/22 08/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 159 175 172 393 703 666
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.252 x 1.496 x 1.372 x 2.812 x 1.039 x 2.956 x
Free Cash Flow 1 -174 -37 -1.35 -198 -206 71.8
ROE (net income / shareholders' equity) 24.3% 21.8% 19.3% 18.5% 64.3% -0.31%
ROA (Net income/ Total Assets) 6.4% 8.89% 8.09% 6.66% 17.8% 2.95%
Assets 1 581.9 635.6 753.1 1,056 2,266 -88.89
Book Value Per Share 2 17.90 22.20 26.70 32.10 64.60 66.00
Cash Flow per Share 2 1.140 3.370 2.780 2.980 0.2700 0.2500
Capex 1 133 8.42 16.4 42.4 413 104
Capex / Sales 17.44% 0.69% 1.29% 2.75% 11.67% 4.75%
Announcement Date 03/09/18 10/09/19 10/12/20 28/10/21 07/09/22 08/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ANG LIFESCIENCES INDIA LIMITED Stock ANG Lifesciences India Limited
-26.11% 8.08M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.19% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+45.62% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.09% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.92% 337B
ASTRAZENECA PLC Stock AstraZeneca PLC
+19.66% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+3.56% 229B
NOVARTIS AG Stock Novartis AG
+13.99% 219B
AMGEN INC. Stock Amgen Inc.
+10.86% 171B
PFIZER, INC. Stock Pfizer, Inc.
-2.78% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ANG6 Stock
  4. Financials ANG Lifesciences India Limited